Journal profile · RESPIRATORY SYSTEM
Journal of Thoracic Disease
ISSN 2072-1439 · eISSN 2077-6624 · Pioneer Bioscience Publishing Company (PBPC) · PEOPLES R CHINA
Journal of Thoracic Disease: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.36; fully open access; APC about USD 1,900; median 62 days to acceptance (100 articles, last 24 months); 978 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Thoracic Disease is published by Pioneer Bioscience Publishing Company (PBPC) and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lung Cancer Diagnosis and Treatment, Pleural and Pulmonary Diseases and Lung Cancer Treatments and Mutations, together about 36.7% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624), founded in Dec 2009, is an international, peer-reviewed, open access journal covering the field of respiratory, lung, heart, esophageal and mediastinal diseases. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured. Published quarterly from December 2009 to December 2011 and bimonthly from January 2012 to December 2013, JTD now follows a monthly publication model. It has been indexed by Web of Science [Science Citation Index Expanded (SCIE)], PubMed/PubMed Central and Scopus. It received an impact factor of 2.3 for the year 2025.
From the journal's Aims & Scope
Research area (LetPub): RESPIRATORY SYSTEM
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lung Cancer Diagnosis and TreatmentMedicine19.8%
- Pleural and Pulmonary DiseasesMedicine8.7%
- Lung Cancer Treatments and MutationsMedicine8.3%
- Tracheal and airway disordersMedicine5.9%
- Esophageal Cancer Research and TreatmentMedicine4.8%
- Lung Cancer Research StudiesMedicine4.8%
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine3.9%
- Respiratory Support and MechanismsMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.36LetPub ·
- Impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 2.9LetPub ·
- CiteScore (publisher) 2025
- 2.9Publisher website ·
- SJR 2026-06
- 0.61LetPub ·
- SNIP 2026-06
- 0.85LetPub ·
- h-index
- 45LetPub ·
- h-index
- 102OpenAlex ·
- i10-index
- 3,761OpenAlex ·
- 2-year mean citedness
- 2.03OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 99.86%LetPub ·
Volume
- Articles per year
- 897LetPub ·
Articles by year OpenAlex count · 11,293 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,083 | 1,083 | 832 |
| 2025 | 978 | 978 | 1,379 |
| 2024 | 808 | 808 | 3,611 |
| 2023 | 701 | 701 | 4,407 |
| 2022 | 522 | 522 | 4,608 |
| 2021 | 725 | 725 | 9,533 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
62 daysMedian, submission to acceptance · P25–P75 43 days – 85 days
- Acceptance to online
- median 31 days (99 articles)
- Submission to online
- median 96 days
- Sample
- 100 articles with submission and acceptance dates (2,195 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to publication (journal-reported)
- about 24 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,900 | Yes | CC BY-NC-ND |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted6
- case reportManuscript categories Word limit Abstract Key words Main text Reference Tables and Figures Structure template Original Article No limit Structured with Backgrou…Length not stated
- literature reviewManuscript categories Word limit Abstract Key words Main text Reference Tables and Figures Structure template Original Article No limit Structured with Backgrou…Length not stated
- original articleManuscript categories Word limit Abstract Key words Main text Reference Tables and Figures Structure template Original Article No limit Structured with Backgrou…Length not stated
- reviewManuscript categories Word limit Abstract Key words Main text Reference Tables and Figures Structure template Original Article No limit Structured with Backgrou…Length not stated
- review articleManuscript categories Word limit Abstract Key words Main text Reference Tables and Figures Structure template Original Article No limit Structured with Backgrou…Length not stated
- systematic reviewManuscript categories Word limit Abstract Key words Main text Reference Tables and Figures Structure template Original Article No limit Structured with Backgrou…Length not stated
Policy excerpts from the journal's websiteAuthorship, License & copyright, Open access
- Authorship 3.2 Authorship and Author contributions
3.2.1 AuthorshipAuthors should meet all four of the ICMJE’s authorship criteria listed below for authorship (1):
Source ↗Publisher website ·- License & copyright 6. COPYRIGHT AND PERMISSIONS
For specifications, please refer to: https://jtd.amegroups.org/page/about/copyright-and-permission
Source ↗Publisher website ·- Open access Open Access Statement
This journal is a peer reviewed, open access journal. All content of the journal is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). All articles published open access will be immediately and permanently free for all to read, download, copy and distribute as defined by the applied license.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Pioneer Bioscience Publishing Company (PBPC)
- Country or region
- PEOPLES R CHINA
- Language
- English
- ISSN
- 2072-1439
- Electronic ISSN
- 2077-6624
- Society / sponsor
- Guangzhou Institute of Respiratory Health
- Official links
FAQ
Frequently asked questions about Journal of Thoracic Disease
What CAS zone is Journal of Thoracic Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Thoracic Disease is in Zone 4 of Medicine, and in Zone 4 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Thoracic Disease?
The latest impact factor listed by LetPub is 2.36; CiteScore 2.9, h-index 102.
How long does peer review take at Journal of Thoracic Disease?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 62 days (interquartile range 43–85 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Thoracic Disease?
According to LetPub and DOAJ records, Journal of Thoracic Disease is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is Journal of Thoracic Disease open access, and what is the APC?
Journal of Thoracic Disease is a fully open-access journal. APC about USD 1,900.
Sources and updates
The facts on this page come from LetPub, DOAJ, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .